Αρχική Uncategorized Beloved Kansas City Jazz Singer Passes Away at 48 After 13-Year Battle...

Beloved Kansas City Jazz Singer Passes Away at 48 After 13-Year Battle with Breast Cancer

Molly Hammer, a jazz and blues singer well known in the Kansas City area, passed away last week at the age of 48 after a 13-year battle with breast cancer. Hammer had initially been diagnosed with the disease in 2008, and it returned in the form of metastatic breast cancer in 2016.

On November 25th, Hammer’s mother Roberta wrote on her daughter’s Facebook page, “My daughter Molly Hammer passed yesterday at 10:30 pm after sharing her life for 13 years with breast cancer. Celebration of Life tentatively scheduled for June 2021.”

Hammer spent years acting on the stage but turned her focus to jazz and blues in 2005. She released four LPs, the last, I’m Feeling Mellow, came out this October. In 2016, she won the Critics’ Choice award for Best Jazz Singer from Kansas City newspaper The Pitch.

Molly Hammer
PHOTO: FACEBOOK/MOLLY HAMMER

Hammer was well-connected to her local music community, with proceeds from her music sales going toward Midwest Music Foundation for musicians’ health care needs.

Her high school choir teacher, Tom Gifford, spoke to KCUR in Kansas City about the potential he saw in her at an early age. Of her role as a narrator in a production of Joseph and the Amazing Technicolor Dream Coat, he said, “If I recall right, we didn’t have to tell the narrator anything about how to do the job, we just said ‘make sure you stand here, make sure you go over there.’ She was just spot on from the very beginning of the rehearsals.”

Molly Hammer
PHOTO: FACEBOOK/MOLLY HAMMER

In 2018, Hammer wrote a piece about her experience with breast cancer for the website 7 Billion Ones. She said after her initial battle with stage 3B breast cancer in 2008, she had a renewed sense of purpose and devoted herself completely to her music goals.

When she began noticing symptoms including tightness in her chest and pains in her hip and pelvis eight years later, she saw her oncologist. That’s when she learned that the cancer was back and had spread to her bones and left lung.

Article continues below

Our Featured Programs

See how we’re making a difference for People, Pets, and the Planet and how you can get involved!

Hammer said she got to work doing the things she wanted to do. She wrote, “I had a great two years on a brand new drug used for women with exactly my kind of breast cancer. It was a form of hormone therapy that allowed me to continue singing, which I did. I had always wanted to travel and I made sure that happened. I went to Paris, Florence, Rome, Mexico, San Francisco, Seattle, New York, Southern California, and I’m not done. Not by a long shot. I recorded my first CD, which was an absolutely amazing experience and I can’t wait to record more.”

At the end of the piece, she said she knew that she was loved, loved tenfold in return, and lived every day with an open heart. She found peace in that.

Gifford praised her openness about her health ordeal, saying, “Her music career is incredible, and she touched so many lives and she was amazing. But I also think that one of her important contributions was that when she got cancer, how open she was to the public.”

He said that was important to people whose loved ones were going through treatment, as well as patients themselves.

Provide Mammograms

Support those fighting Breast Cancer at The Breast Cancer Site for free!

Whizzco Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...

Καρκίνος: Ευεργετική για τους καρκινοπαθείς η άσκηση

Σημαντικά ωφέλη προσφέρει η άσκηση, ακόμη και σε ασθενείς με καρκίνο. Οι περισσότεροι ασθενείς αγνοούν τα οφέλη που μπορεί να έχει γι’ αυτούς η συχνή...

Prostate Cancer

The article is provided by Scientific Communications Officer of NIPD Genetics, Ms Marina Charitou (MSc) Prostate Cancer Awareness Prostate cancer is the second most common cancer...
- Advertisment -

Ροή Ειδήσεων

Discovering the BRCA2 gene – 25 years on

A breast cancer cell. Credit: LRI EM Unit. 25 years ago, a team of our scientists were celebrating. Their risky strategy had paid off. “You...

Newly Developed RSClin Provides Prognostic Information in HR-positive, HER2-negative Early Breast Cancer

The online RSClin tool incorporating clinical-pathological data and the results of a 21-gene recurrence score (RS) was able to estimate the risk of distant...

Embracing Bravery When You Have a Genetic Cancer Disease

Emily Pinto Billcheck is a licensed social worker with experience in the mental health field. She is a von Hippel-Lindau (VHL) patient who inherited VHL from her...

Chemotherapy Administered for the First Diagnosed Testicular Cancer Reduces the Risk of Metachronous Contralateral Testicular Cancer Occurrence

Patients aged less than 30 years upon diagnosis of testicular cancer and those treated with surgery only are at higher risk of developing a...

New Research Looks for More Effective Breast Cancer Treatments for Black Women

Breast cancer affects people across all different backgrounds, but Black women in particular are more apt to get aggressive forms of the disease. They’re...

Palbociclib Plus Endocrine Therapy Does Not Improve PFS over Capecitabine in HR-positive, HER2-negative Aromatase Inhibitor Resistant Metastatic Breast Cancer

Although patients with hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative, aromatase inhibitor resistant metastatic breast cancer maintained quality of life...